Strategic Initiative

Slingshot members are tracking this corporate initiative:

Baxalta (SHPG) Pays $10.3MM to Return Blood Cancer Candidate Pacritinib to CTI BioPharma (CTIC)

Source Link:
https://www.sec.gov/Archives/edgar/data/891293/000089129316000188/a8-k102116.htm

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
SHPG
100%
Baxalta
100%
CTIC
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Strategic Initiative Date
Announcement Date:
Oct 24, 2016
Projected Implementation:
Q4, 2016
Relevance Tracked Until:
Q4, 2017
Related Projects Image

  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Pacritinib, Blood Cancer Candidate
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.